| Title | Optimizing the management of metastatic colorectal cancer. | | Author(s) | Comella P, Casaretti R, Avallone A, Franco L | | Institution | Unit of Medical Oncology, Department of Gastro-Intestinal Tract Tumours, National Tumour Institute, Via M. Semmola, 80131 Naples, Italy. | | Source | Crit Rev Oncol Hematol 2009 Oct 16. | | Abstract | The prognosis of patients with metastatic colorectal cancer has significantly improved in the last few years, with the introduction into the clinical practice of new cytotoxic treatments, the availability of non-cross resistant agents after the front-line treatment failure, and the combination of targeted agents (i.e., the inhibitors of the epidermal growth factor and vascular endothelial growth factor pathways) with conventional drugs. All these options must be incorporated into a complex strategy of management, in which a customized management according to the disease status, with an intensified induction approach followed by maintenance (and reinduction), should be investigated. | | Language | ENG | | Pub Type(s) | JOURNAL ARTICLE
| | PubMed ID | 19837601 |
|
